NEW YORK, Feb. 07, 2017 -- Pzena Investment Management, Inc. (NYSE:PZN) today reported its preliminary assets under management as of January 31, 2017.
AUM for month-end January 2017, month-end December 2016, and month-end January 2016 are listed below:
| Pzena Investment Management, Inc. Assets Under Management1 ($ billions) | ||||||||||||
| As of | As of | As of | ||||||||||
| January 31, 2017 | December 31, 2016 | January 31, 2016 | ||||||||||
| Account Type | ||||||||||||
| Institutional Accounts | $ | 17.5 | $ | 16.9 | $ | 13.8 | ||||||
| Retail Accounts | 13.4 | 13.1 | 10.7 | |||||||||
| Total | $ | 30.9 | $ | 30.0 | $ | 24.5 | ||||||
| Investment Strategy2 | ||||||||||||
| U.S. Value Strategies | ||||||||||||
| Large Cap Value | $ | 9.5 | $ | 9.4 | $ | 9.1 | ||||||
| Mid Cap Value | 2.5 | 2.5 | 1.9 | |||||||||
| Value | 2.0 | 2.0 | 1.6 | |||||||||
| Small Cap Value | 1.6 | 1.6 | 1.1 | |||||||||
| Other U.S. Strategies | 0.1 | 0.1 | — | |||||||||
| Total U.S. Value Strategies | 15.7 | 15.6 | 13.7 | |||||||||
| Global & Non-U.S. Value Strategies | ||||||||||||
| International Value | 5.1 | 4.9 | 3.8 | |||||||||
| Global Value | 4.8 | 4.6 | 3.9 | |||||||||
| Emerging Markets Value | 2.8 | 2.6 | 1.8 | |||||||||
| European Value | 2.4 | 2.1 | 1.1 | |||||||||
| Other Global & Non-U.S. Value Strategies | 0.1 | 0.2 | 0.2 | |||||||||
| Total Global & Non-U.S. Value Strategies | 15.2 | 14.4 | 10.8 | |||||||||
| Total | $ | 30.9 | $ | 30.0 | $ | 24.5 | ||||||
| Account Domicile | ||||||||||||
| U.S. | $ | 21.5 | $ | 21.1 | $ | 17.9 | ||||||
| Non-U.S. | 9.4 | 8.9 | 6.6 | |||||||||
| Total | $ | 30.9 | $ | 30.0 | $ | 24.5 | ||||||
| 1 Numbers may be subject to rounding. | ||||||||||||
| 2 Inclusive of our Expanded Value, Focused Value and variations thereof. | ||||||||||||
About Pzena
Pzena Investment Management, LLC, the firm's operating company, is a value-oriented investment management firm. Founded in 1995, Pzena Investment Management has built a diverse, global client base. More firm and stock information is posted at www.pzena.com.
Forward-Looking Statements
This press release may contain, in addition to historical information, forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended. Forward-looking statements provide the Company’s current views, expectations, or forecasts of future events and performance, and include statements about our expectations, beliefs, plans, objectives, intentions, assumptions and other statements that are not historical facts. Words or phrases such as “anticipate,” “believe,” “continue,” “ongoing,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project” or similar words or phrases, or the negatives of those words or phrases, may identify forward-looking statements, but the absence of these words does not necessarily mean that a statement is not forward-looking.
Among the factors that could cause actual results to differ from those expressed or implied by a forward-looking statement are those described in the sections entitled “Risk Factors” and “Management's Discussion and Analysis of Financial Condition and Results of Operations” in the Company's Annual Report on Form 10-K, as filed with the SEC on March 14, 2016 and in the Company's Quarterly Reports on Form 10-Q as filed with the SEC. In light of these risks, uncertainties, assumptions, and factors, actual results could differ materially from those expressed or implied in the forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date stated, or if no date is stated, as of the date of this release.
The Company is not under any obligation and does not intend to make publicly available any update or other revisions to any forward-looking statements to reflect circumstances existing after the date of this release or to reflect the occurrence of future events even if experience or future events make it clear that any expected results expressed or implied by those forward-looking statements will not be realized.
Contact: Gary Bachman, 212-355-1600 or [email protected].


Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 



